Related Experiment Video

Updated: Jun 2, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

Sox17 regulates proliferation and cell cycle during gastric cancer progression

Yan-Wei Ye1, Jiang-Hong Wu, Chun-Meng Wang

  • 1Department of Abdominal Surgery, Shanghai Cancer Center, Fu Dan University, 270 Dong-An Road, Shanghai, China.

Cancer Letters
|April 26, 2011
PubMed

Insights

Sox17, a key transcription factor, is downregulated in gastric cancer. Its reduced expression promotes tumor cell proliferation and cell cycle progression, highlighting its potential as a diagnostic and therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • Sox17 antagonizes Wnt/β-catenin signaling in various cancers.
  • The role of Sox17 in gastric cancer tumorigenesis remains largely unexplored.

Purpose of the Study:

  • To investigate the function of Sox17 in gastric cancer development and progression.
  • To determine Sox17's potential as a biomarker and therapeutic target.

Main Methods:

  • Real-time PCR to assess Sox17 expression in gastric cancer tissues.
  • Small interfering RNA (siRNA) to knockdown Sox17 in MKN45 gastric cancer cells.
  • Functional assays including proliferation, clonogenic, cell-cycle, apoptosis, and Western blot analyses.

Main Results:

  • Sox17 expression was significantly lower in gastric cancer tissues compared to normal tissues.
  • Sox17 knockdown enhanced cell proliferation, cloning efficiency, and activated the cell cycle.
  • Downregulation of Sox17 led to increased CyclinD1 and decreased p27(Kip1) expression, without affecting apoptosis markers.

Conclusions:

  • Sox17 plays a crucial role in gastric cancer progression by regulating proliferation and cell cycle.
  • Sox17 represents a potential diagnostic and prognostic biomarker for gastric cancer.
  • Targeting Sox17 could offer a novel therapeutic strategy for gastric cancer treatment.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...